| P50 | author | David S Boyle | Q89149882 |
| P2093 | author name string | Jason Cantera | |
| | Lorraine Lillis | |
| | Jonas M Winchell | |
| | Maureen H Diaz | |
| | Michael Kalnoky | |
| | Heather White | |
| | James Gallarda | |
| | Shivani G Beall | |
| P2860 | cites work | Inhibition of PCR amplification by phytic acid, and treatment of bovine fecal specimens with phytase to reduce inhibition | Q45027650 |
| | Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi | Q46226013 |
| | Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries | Q46949758 |
| | Genotyping Multi-Drug Resistant M. tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray | Q47203483 |
| | Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community. | Q47274192 |
| | Medical Schools in Fragile States: Implications for Delivery of Care | Q49720301 |
| | A bench-top automated workstation for nucleic acid isolation from clinical sample types. | Q52313960 |
| | Inhibition mechanisms of hemoglobin, immunoglobulin G, and whole blood in digital and real-time PCR. | Q52674709 |
| | Automated TruTip nucleic acid extraction and purification from raw sputum | Q56395664 |
| | Simplicity of use: a critical feature for widespread adoption of diagnostic technologies in low-resource settings | Q84554570 |
| | Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation | Q28469353 |
| | Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa | Q28533713 |
| | Diagnostic point-of-care tests in resource-limited settings | Q33590492 |
| | Demonstrating a multi-drug resistant Mycobacterium tuberculosis amplification microarray | Q33635069 |
| | Purification and characterization of PCR-inhibitory components in blood cells | Q33971131 |
| | Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. | Q33974884 |
| | Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa | Q34340867 |
| | Rapid diagnosis of Mycobacterium tuberculosis with Truenat MTB: a near-care approach | Q34562015 |
| | Akonni TruTip(®) and Qiagen(®) methods for extraction of fetal circulating DNA--evaluation by real-time and digital PCR. | Q34927319 |
| | Inhibition of recombinase polymerase amplification by background DNA: a lateral flow-based method for enriching target DNA. | Q35538344 |
| | Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. | Q35598939 |
| | Differential Diagnosis of Malaria on Truelab Uno®, a Portable, Real-Time, MicroPCR Device for Point-Of-Care Applications | Q35897527 |
| | Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi | Q36504564 |
| | Rapid tests for sexually transmitted infections (STIs): the way forward | Q36675814 |
| | Standardized methods to generate mock (spiked) clinical specimens by spiking blood or plasma with cultured pathogens | Q36739562 |
| | Point-of-care nucleic acid testing for infectious diseases | Q37104218 |
| | Mucins, mucus, and sputum | Q37388225 |
| | Development, validation and testing costs of an in-house real-time PCR assay for the detection of Chlamydia trachomatis | Q37835035 |
| | PCR inhibitors - occurrence, properties and removal | Q38022772 |
| | Multicenter comparison of nucleic acid extraction methods for detection of severe acute respiratory syndrome coronavirus RNA in stool specimens | Q38472936 |
| | Comparing laboratory costs of smear/culture and Xpert(®) MTB/RIF-based tuberculosis diagnostic algorithms | Q39291055 |
| | Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens | Q39901199 |
| | Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model | Q40013468 |
| | Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing | Q40598889 |
| | Evaluation of five commercial methods for the extraction and purification of DNA from human faecal samples for downstream molecular detection of the enteric protozoan parasites Cryptosporidium spp., Giardia duodenalis, and Entamoeba spp. | Q40652957 |
| | Preparation of inocula for experimental infection of blood with Streptococcus pneumoniae | Q40805945 |
| | Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. | Q42833328 |
| | Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics? | Q44180144 |
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0215753 | |
| P577 | publication date | 2019-04-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings | |
| P478 | volume | 14 | |